Astec Lifesciences
Ticker > Company >

Astec Lifesciences share price

Astec Lifesciences Ltd.

NSE: ASTEC BSE: 533138 SECTOR: Pesticides & Agrochemicals  64k   342   19

648.75
-0.80 (-0.12%)
BSE: 09 May 04:01 PM

Price Summary

Today's High

₹ 658.25

Today's Low

₹ 635.95

52 Week High

₹ 1487.65

52 Week Low

₹ 635.95

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1272.29 Cr.

Enterprise Value

₹ 1764.79 Cr.

No. of Shares

1.96 Cr.

P/E

0

P/B

5.44

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  119.36

CASH

₹ 1.39 Cr.

DEBT

₹ 493.89 Cr.

Promoter Holding

70.87 %

EPS (TTM)

₹  -68.74

Sales Growth

-27.06%

ROE

-11.94 %

ROCE

-4.52%

Profit Growth

-284.12 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-27.06%
3 Year-6.18%
5 Year1.24%

Profit Growth

1 Year-284.12%
3 Year-189.89%
5 Year-205.66%

ROE%

1 Year-11.94%
3 Year6.61%
5 Year12.88%

ROCE %

1 Year-4.52%
3 Year8.48%
5 Year13.62%

Debt/Equity

1.341

Price to Cash Flow

125.58

Interest Cover Ratio

-1.4511

CFO/PAT (5 Yr. Avg.)

1.48666237895097

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 70.87 0.00
Dec 2024 66.75 0.00
Sep 2024 66.75 0.00
Jun 2024 66.75 0.00
Mar 2024 66.75 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a high promoter holding of 70.87%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 5.308915798099.

 Limitations

  • The company has shown a poor profit growth of -189.88934910891% for the Past 3 years.
  • The company has shown a poor revenue growth of -6.18299202680159% for the Past 3 years.
  • Company has a poor ROE of 6.61394301952313% over the past 3 years.
  • Company has low Interest coverage ratio of -1.4511.
  • Company has contingent liabilities of 212.4452 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 153.75 69.37 98.55 93.86 119.53
Total Expenditure 141.04 115.62 118.28 99.6 114
Operating Profit 12.71 -46.25 -19.73 -5.74 5.52
Other Income 2.03 0.91 1.98 1.89 0.78
Interest 6.68 7.05 9.34 9.92 10.4
Depreciation 9.02 9.28 11.49 11.42 11.59
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.96 -61.67 -38.57 -25.18 -15.69
Tax 0.03 -21.93 0 15.22 0.41
Profit After Tax -0.99 -39.74 -38.57 -40.4 -16.1
Adjusted EPS (Rs) -0.5 -20.26 -19.67 -20.6 -8.21

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 522.22 554.87 676.57 628.17 458.18
Total Expenditure 437.02 443.47 522.48 551.9 464.08
Operating Profit 85.2 111.4 154.08 76.27 -5.9
Other Income 11.93 7.78 10.46 13.04 5.58
Interest 12.64 4.79 9.09 20.74 25.24
Depreciation 23.22 25.71 34.42 33.71 36.31
Exceptional Items 0 0 0 0 0
Profit Before Tax 61.27 88.67 121.04 34.85 -61.88
Tax 13.8 23.98 31.22 9.33 -14.89
Net Profit 47.47 64.69 89.82 25.52 -46.99
Adjusted EPS (Rs.) 24.26 33.03 45.83 13.02 -23.96

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 19.57 19.59 19.6 19.61 19.61
Total Reserves 226.87 289.12 376.38 399.19 349.07
Borrowings 0 40 0 10.86 199
Other N/C liabilities 6.78 6.23 38.28 22.86 9.22
Current liabilities 318.88 322.97 491.07 526.33 397.25
Total Liabilities 572.1 677.9 925.32 978.85 974.15
Assets
Net Block 193.68 212.67 339.88 318.35 385.78
Capital WIP 22.11 111.68 13.73 112.38 148.47
Intangible WIP 2 4.04 9.09 14.22 16.57
Investments 0.49 0.43 0.43 0.43 0.43
Loans & Advances 22.13 18.66 46.81 35.37 25.42
Other N/C Assets 0 0 0 0 0
Current Assets 331.69 330.43 515.38 498.09 397.48
Total Assets 572.1 677.9 925.32 978.85 974.15
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 61.27 88.67 121.04 34.85 -61.88
Adjustment 37.57 29.52 44.11 50.61 63.58
Changes in Assets & Liabilities 87.92 -103.26 -112.61 -6.28 10.36
Tax Paid -18.2 -22.99 -29.13 -4.86 -1.93
Operating Cash Flow 168.56 -8.06 23.41 74.32 10.13
Investing Cash Flow -73.81 -73.11 -103.57 -112.07 -134.98
Financing Cash Flow -94.64 81.23 80.37 37.66 124.85
Net Cash Flow 0.11 0.06 0.22 -0.09 0

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 66.75 66.75 66.75 66.75 70.87
ashok vishwanath hiremath... 1.99 1.99 1.99 1.99 1.99
godrej agrovet limited 64.76 64.76 64.75 64.75 64.75
nadir burjorji godrej - - - - 2.06
nisaba godrej - - - - 0.69
pirojsha adi godrej - - - - 0.69
tanya arvind dubash - - - - 0.69
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 33.25 33.25 33.25 33.25 29.13
ajay kumar aggarwal - - - - 1.52
investor education and pr... 0.05 0.05 - 0.06 0.06
nippon life india trustee... 2.39 2.39 2.39 2.39 2.35
shreans daga 1.90 1.90 1.69 1.02 -
shreyans vasantkumar meht... - - - 1.10 -
investor education and pr... - - 0.06 - -
kaushik daga 1.67 1.67 1.51 - -
icici prudential multicap... 5.30 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Astec Lifesciences informs about press release 24 Apr, 2:49 PM Astec Lifesciences - Quaterly Results 23 Apr, 5:48 PM Astec Lifesciences - Quaterly Results 23 Apr, 5:48 PM Astec Lifesciences - Quaterly Results 23 Apr, 5:48 PM Astec Lifesciences raises Rs 49 crore through NCDs 28 Mar, 11:29 AM Astec Lifesciences gets nod for equity investment in proposed SPV 28 Jan, 11:58 AM Astec Lifesciences - Quaterly Results 27 Jan, 5:47 PM Astec Lifesciences - Quaterly Results 27 Jan, 5:47 PM Astec Lifesciences - Quaterly Results 27 Jan, 5:47 PM Astec Lifesciences - Quaterly Results 25 Oct, 6:21 PM Astec Lifesciences - Quaterly Results 25 Oct, 6:21 PM Astec LifeSciences informs about resignation of independent director 7 Oct, 2:15 PM Astec LifeSciences informs about disclosure 1 Aug, 10:59 AM Astec Lifesciences - Quaterly Results 29 Jul, 3:18 PM Astec Lifesciences - Quaterly Results 29 Jul, 3:18 PM Astec Lifesciences - Quaterly Results 29 Jul, 3:18 PM Astec Lifesciences informs about annual report 9 Jul, 4:45 PM Astec Lifesciences informs about updates 26 Jun, 5:24 PM Astec Lifesciences - Quaterly Results 2 May, 4:24 PM Astec Lifesciences - Quaterly Results 2 May, 4:24 PM Astec Lifesciences - Quaterly Results 2 May, 4:24 PM Astec LifeSciences informs about closure of trading window 19 Apr, 11:01 AM Astec Lifesciences - Quaterly Results 25 Jan, 4:46 PM Astec Lifesciences - Quaterly Results 25 Jan, 4:46 PM Astec Lifesciences - Quaterly Results 25 Jan, 4:46 PM Astec Lifesciences informs about compliances-certificate 11 Jan, 12:58 PM Astec Lifesciences - Quaterly Results 27 Oct, 5:05 PM Astec Lifesciences - Quaterly Results 27 Oct, 5:05 PM Astec Lifesciences - Quaterly Results 27 Oct, 5:05 PM Astec Lifesciences raises Rs 49 crore through NCDs 23 Aug, 9:25 AM Astec Lifesciences informs about disclosure 2 Aug, 2:31 PM Astec Lifesciences - Quaterly Results 27 Jul, 3:18 PM Astec Lifesciences - Quaterly Results 27 Jul, 3:18 PM Astec Lifesciences - Quaterly Results 27 Jul, 3:18 PM Astec Lifesciences - Quaterly Results 2 May, 5:51 PM Astec Lifesciences - Quaterly Results 2 May, 5:51 PM Astec Lifesciences - Quaterly Results 2 May, 5:51 PM Astec LifeSciences launches R&D Center in Rabale 11 Apr, 2:58 PM Astec Lifesciences gets nod to raise Rs 50 crore via NCDs 31 Jan, 12:59 PM Astec Lifesciences - Quaterly Results 30 Jan, 5:10 PM Astec Lifesciences - Quaterly Results 30 Jan, 5:10 PM Astec Lifesciences - Quaterly Results 30 Jan, 5:10 PM Astec Lifesciences informs about outcome of board meeting 29 Oct, 11:49 AM Astec Lifesciences - Quaterly Results 28 Oct, 4:37 PM Astec Lifesciences - Quaterly Results 28 Oct, 4:37 PM Astec Lifesciences - Quaterly Results 28 Oct, 4:37 PM Astec Lifesciences informs about disclosure 14 Oct, 5:08 PM Astec LifeSciences submits newspaper advertisement 17 Aug, 4:53 PM Astec Lifesciences informs about postal ballot notice 17 Aug, 12:28 PM Astec Lifesciences - Quaterly Results 25 Jul, 3:48 PM

Astec Lifesciences Stock Price Analysis and Quick Research Report. Is Astec Lifesciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Astec Lifesciences stock price today is Rs 649.7. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Astec Lifesciences . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Astec Lifesciences has a PE ratio of -9.45166658907872 which is low and comparatively undervalued .

  • Share Price: - The current share price of Astec Lifesciences is Rs 649.7. One can use valuation calculators of ticker to know if Astec Lifesciences share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Astec Lifesciences has ROA of -4.8118 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Astec Lifesciences has a Current ratio of 1.0006 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Astec Lifesciences has a ROE of -11.9449 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Astec Lifesciences has a Debt to Equity ratio of 1.341 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Astec Lifesciences has reported revenue growth of -27.0606 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Astec Lifesciences for the current financial year is -1.28829084245582 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Astec Lifesciences is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Astec Lifesciences is Rs -68.7392 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Astec Lifesciences in Ticker for free. Also, one can get the intrinsic value of Astec Lifesciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Astec Lifesciences

Astec LifesciencesLtd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Astec Lifesciences Ltd. is a leading Indian pharmaceutical company committed to providing high-quality products to customers. The company specializes in the manufacturing and marketing of agro-chemicals, pharmaceutical intermediates, and specialty chemicals.

Astec Lifesciences Ltd. Share Price

Astec Lifesciences Ltd. is a publicly traded company listed on the BSE and NSE. The stock's current market price can be checked on our website's Astec Lifesciences Ltd. stock analysis page. We provide real-time stock prices that are updated every few minutes throughout the trading day.

Astec Lifesciences Ltd. Balance Sheet

Astec Lifesciences Ltd. balance sheet is an important tool for investors to analyze the company's financial standing. Our website's Astec Lifesciences Ltd. stock analysis page provides access to the company's annual reports and quarterly financial statements. Using our premium feature like DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, investors can calculate the fair value of the company.

Astec Lifesciences Ltd. Annual Report

Astec Lifesciences Ltd. annual reports provide a comprehensive overview of the company's performance over the year. Our website provides downloadable annual reports that include the company's financial statements, management discussion, and analysis of the company's operations. Investors can use our pre-built screening tools to compare the company's performance with its peers.

Astec Lifesciences Ltd. Dividend

Astec Lifesciences Ltd. has a consistent track record of paying dividends to its shareholders. Our website's Astec Lifesciences Ltd. stock analysis page provides information on the company's dividend history. You can also set up a customized alert on our website to get notified when the company declares a dividend.

Astec Lifesciences Ltd. Quarterly Result

Astec Lifesciences Ltd. quarterly financial statements provide insights into the company's short-term performance. Our website provides downloadable quarterly results that include the company's income statement, balance sheet, and cash flow statement. Using our premium feature, investors can calculate important profitability ratios and compare them with the industry.

Astec Lifesciences Ltd. Stock Price

Astec Lifesciences Ltd. stock price can be monitored using our real-time stock price tracker on our website's stock analysis page. Our users can view the company's historical stock prices and set up customized alerts to track price changes.

Astec Lifesciences Ltd. Price Chart

Astec Lifesciences Ltd. price charts are a graphical representation of the company's stock price movements over a specific period. Our website's Astec Lifesciences Ltd. stock analysis page provides users with interactive price charts that can be customized by the user to display various technical indicators.

Astec Lifesciences Ltd. News

Our website provides the latest news and alerts related to Astec Lifesciences Ltd. The news section of our Astec Lifesciences Ltd. stock analysis page provides news stories related to the company from various trusted sources.

Astec Lifesciences Ltd. Concall and Transcripts

Astec Lifesciences Ltd. conference call transcripts provide users with detailed information on the company's internal workings. Our website provides downloadable transcripts from past calls that include management discussions on the company's performance and future plans.

Astec Lifesciences Ltd. Investor Presentations

Astec Lifesciences Ltd. investor presentations provide information on the company's strategy, financial performance, and future plans. Users can download these presentations from our website and use them to better understand the company's operations.

Astec Lifesciences Ltd. Promoters

Astec Lifesciences Ltd. promotes a shareholder-friendly culture that is reflected in its consistent dividend payouts and transparency in reporting. Our website's Astec Lifesciences Ltd. stock analysis page provides users with information on the company's promoters.

Astec Lifesciences Ltd. Shareholders

Astec Lifesciences Ltd. is owned by a diverse group of shareholders that include institutional investors and retail investors. Our website's Astec Lifesciences Ltd. stock analysis page provides users with information on the company's major shareholders and changes in their shareholding pattern.

Overall, our website's Astec Lifesciences Ltd. stock analysis page provides investors with detailed information on the company's performance, financial statements, and news. Our pre-built screening tools and premium features allow investors to evaluate the company's performance and calculate its fair value. 

Astec Lifesciences Balance Sheet Analysis

Astec Lifesciences Equity and Liabilities

Astec Lifesciences has shown a consistent increase in its Share Capital from Rs 19.57 Cr in March 2020 to Rs 19.61 Cr by March 2024. Total Reserves saw a significant rise from Rs 226.87 Cr in March 2020 to Rs 399.19 Cr in March 2023, before witnessing a decrease to Rs 349.07 Cr in March 2024. Notably, the Borrowings fluctuated, touching a high of Rs 199 Cr in March 2024 from no borrowings in March 2020. This indicates a strategic shift in the company's financing.

Astec Lifesciences Assets

On the assets front, Astec Lifesciences has increased its Net Block from Rs 193.68 Cr in March 2020 to Rs 385.78 Cr in March 2024, showcasing substantial growth in its fixed assets. The Capital Work in Progress (WIP) peaked at Rs 148.47 Cr in March 2024, indicating ongoing investments in the company’s future growth. Current Assets have seen variations, peaking in March 2022 at Rs 515.38 Cr and settling at Rs 397.48 Cr by March 2024.

Astec Lifesciences Investments and Reserves

The company has maintained a conservative stance on its Investments, which have remained nearly constant. The fluctuation in Total Reserves, especially the dip in March 2024, merits attention from investors looking into the company’s retained earnings and overall financial health.

This data represents an analysis for the Standalone Balance sheet of Astec Lifesciences.

Investors analyzing this data might also be interested in understanding how Astec Lifesciences' financial strategies and asset management align with broader trends in the pharmaceutical sector or how they compare to market movements on the NSE and BSE.

Read More
X